ArticleCancer immunology, immunotherapy : CII2007

Complement insufficiency limits efficacy in a xenograft model of hyperacute rejection for cancer therapy.

James M G Larkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.